CS
Chemmenkotil Surendran
About Chemmenkotil Surendran
Data last updated:
Chemmenkotil Surendran is a Managing Director at Metropolis Healthcare Limited (since 2025), Director at Core Diagnostics Private Limited (since 2025) and Director at Metropolis Quality Solutions Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1,466 Cr; the largest is Metropolis Healthcare Limited at ₹1,346 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Metropolis Healthcare Limited L73100MH2000PLC192798 | Managing Director | 01 Jun 2025 | 2000 | ₹1,346 Cr (FY 2025) | Active |
 Core Diagnostics Private Limited U85100HR2012PTC046376 | Director | 21 Mar 2025 | 2012 | ₹120 Cr (FY 2025) | Active |
 Metropolis Quality Solutions Private Limited U74909MH2025PTC457187 | Director | 15 Sep 2025 | 2025 | Active | |
| Metropolis Foundation U88100MH2024NPL424644 | Director | 24 Oct 2024 | 2024 | Active |
Board colleagues of Chemmenkotil Surendran
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chemmenkotil Surendran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemmenkotil Surendran
Chemmenkotil Surendran currently holds 4 directorships: Metropolis Healthcare Limited (Managing Director, since 01 Jun 2025, revenue ₹1,346 Cr (FY 2025)); Core Diagnostics Private Limited (Director, since 21 Mar 2025, revenue ₹120 Cr (FY 2025)); Metropolis Quality Solutions Private Limited (Director, since 15 Sep 2025); Metropolis Foundation (Director, since 24 Oct 2024).
Chemmenkotil Surendran was first appointed on 24 Oct 2024 as Director at Metropolis Foundation. The most recent appointment on record is 15 Sep 2025 at Metropolis Quality Solutions Private Limited.
The 2 current companies of Chemmenkotil Surendran that report revenue have a combined latest revenue of ₹1,466 Cr: Metropolis Healthcare Limited ₹1,346 Cr (FY 2025); Core Diagnostics Private Limited ₹120 Cr (FY 2025).
The current boards of Chemmenkotil Surendran's companies include Ameera Sushil Shah (Metropolis Healthcare Limited), Aparna Chetan Rajadhyaksha (Metropolis Healthcare Limited), Hemant Sachdev (Metropolis Healthcare Limited), Kamlesh Chandrashekhar Kulkarni (Metropolis Healthcare Limited), Purvi Sheth (Metropolis Healthcare Limited), Rehan Khan Abbas (Metropolis Healthcare Limited), among others.